XML 51 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Note 11 - Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Notes Tables  
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Years Ended December 31,

 
  

2020

  

2019

  

2018

 

Stock options and SARs

 $1,321  $407  $984 

Restricted stock

  777   835   551 

Performance shares

  432   243   729 

Total share-based compensation expense

 $2,530  $1,485  $2,264 
             

Related income tax benefit

 $286  $262  $282 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Years Ended December 31,

 
  

2020

  

2019

  

2018

 

Stock Options:

            

Risk free interest rate

  0.1% - 1.4%   1.7% - 2.5%   2.6% - 2.9% 

Expected award life (years)

  3-10   3-10   3-10 

Expected volatility

  35.6% - 61.5%   34.2% - 38.8%   35.4% - 42.1% 

Expected dividend yield

  1.9% - 5.3%   2.3% - 2.5%   1.6% - 2.1% 

Weighted average fair value per share at grant date

 $2.36  $3.96  $5.93 
             

SARs:

            

Risk free interest rate

  0.2% - 1.4%   2.4%  2.6%

Expected award life (years)

  3   3   3 

Expected volatility

  35.6% - 55.8%   34.8%  38.1%

Expected dividend yield

  3.6% - 5.3%   2.3%  1.6%

Weighted average fair value per share at grant date

 $2.18  $3.97  $6.06 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
                
           Weighted Average   Aggregate 
   No. of   Weighted Average   Remaining Life   Intrinsic Value 
   Shares   Exercise Price   (in years)   (in thousands) 

Outstanding, January 1, 2020

  701,131  $16.82   2.95  $714 

Granted

  560,125   9.41         

Exercised

  (154,396)  14.01         
Lapsed or cancelled (136,838)   17.25         

Outstanding, December 31, 2020

  970,022   12.92   3.74   11,128 
Exercisable, December 31, 2020  279,707   17.41   2.41   1,664 
Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]
                
           Weighted Average   Aggregate 
   No. of   Weighted Average   Remaining Life   Intrinsic Value 
   Shares   Exercise Price   (in years)   (in thousands) 

Outstanding, January 1, 2020

  206,700  $18.67   2.04  $- 

Granted

  225,625   10.08         

Exercised

  (46,696)  16.46         
Lapsed or cancelled (68,501)   15.97         

Outstanding, December 31, 2020

  317,128   13.47   3.36   2,031 
Exercisable, December 31, 2020  79,372   20.42   1.56   238 
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
      Weighted Average 
  

No. of

  

Grant Date

 
  

Shares

  

Fair Value

 

Outstanding, January 1, 2020

  151,166  $18.44 

Granted

  67,204   13.52 

Vested

  (43,706)  18.30 

Forfeited

  (17,420)  14.24 

Outstanding, December 31, 2020

  157,244   16.84 
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
      Weighted Average 
  

No. of

  

Grant Date

 
  

Shares

  

Fair Value

 

Outstanding, January 1, 2020

  194,012  $19.77 

Granted

  25,000   12.00 

Vested

  (5,892)  16.97 

Forfeited

  (26,856)  23.46 

Outstanding, December 31, 2020

  186,264   18.28